Neuroimmune interactions and psychologycal stress induced by cohabitation with a sick partner: a review.

Curr Pharm Des

Neuroimmunomodulation Research Group, Departamento de Patologia, Faculdade de Medicina Veterinaria e Zootecnia, USP, Av. Prof. Dr. Orlando Marques de Paiva, 87, CEP: 05508-270.

Published: April 2015

This study reviews the neuroimmunological consequences elicited in mice from long-term cohabitation with tumor-bearing conspecifics. Two types of experiments were performed; one used Swiss female mice and Ehrlich tumor cells, and the other used C57Bl/6 female mice and B16F10 melanoma cells. The female Swiss mice and the C57Bl/6 mice were divided into two groups, i.e., control and experimental. One mouse in each control pair was treated with control solutions (1.0 mL/kg); the other was kept undisturbed and called the 'companion of health partner' (CHP). One mouse in each experimental pair was inoculated with 5 x 10(6) Ehrlich tumor cells or with 10(6) murine B16-F10 melanoma cells; the other mouse, which was the subject of the performed studies, was left undisturbed and called the 'companion of sick partner' (CSP). Although we used two different strains of mice and two different tumor types, the CSP mice presented, in relation to the CHP mice, an increased locomotion in the open field and plus maze apparatuses and no changes in the corticosterone serum levels before and after the immobilization-stress challenge. The Swiss CSP mice showed a reduced level and an increased turnover rate of hypothalamic noradrenaline (NE), as well as increased plasmatic levels of adrenaline and NE. Changes in the immune cell phenotype and activity were also observed in the Swiss and C57Bl/6 CSP mice. The study found that odor cues left by the Ehrlich tumor-injected Swiss mice are aversive and may therefore be responsible for the neuroimmune changes reported in the CSP mice. It is proposed that the final neural link between the neuroimmunological changes observed in the CSP mice involves psychogenic stress imposed by the housing condition and the activation of the brain catecholaminergic pathways and the sympathetic nervous systems.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612820666140130204657DOI Listing

Publication Analysis

Top Keywords

csp mice
20
mice
13
female mice
8
ehrlich tumor
8
tumor cells
8
melanoma cells
8
swiss mice
8
undisturbed called
8
called 'companion
8
csp
6

Similar Publications

Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.

Science

January 2025

Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.

The most advanced monoclonal antibodies (mAbs) and vaccines against malaria target the central repeat region or closely related sequences within the circumsporozoite protein (PfCSP). Here, using an antigen-agnostic strategy to investigate human antibody responses to whole sporozoites, we identified a class of mAbs that target a cryptic PfCSP epitope that is only exposed after cleavage and subsequent pyroglutamylation (pGlu) of the newly formed N terminus. This pGlu-CSP epitope is not targeted by current anti-PfCSP mAbs and is not included in the licensed malaria vaccines.

View Article and Find Full Text PDF

Vaccines targeting the complex pre-erythrocytic stage of Plasmodium parasites may benefit from the inclusion of multiple antigens. However, discerning protective effects can be difficult because newer candidates may not be as protective as leading antigens like the circumsporozoite protein (CSP) in the conventional pre-clinical mouse model. We developed a modified mouse model challenge strategy that maximizes the contribution of T cells induced by novel candidate antigens at the sporozoite challenge time point and used this approach to test Plasmodium P36 and P52 vaccine candidates alone and in concert with non-protective doses of CSP.

View Article and Find Full Text PDF

RTS,S and R21 are the only vaccines recommended by the WHO to protect children from Plasmodium falciparum (Pf) clinical malaria. Both vaccines target the Pf sporozoite surface protein circumsporozoite protein (CSP). Recent studies showed that human antibodies neutralize Pf sporozoites most efficiently when simultaneously binding to the PfCSP NANP repeat and the NPDP junction domain.

View Article and Find Full Text PDF

Introduction: ProC6C is a multi-stage malaria vaccine which includes Circumsporozoite Protein (PfCSP), Pfs48/45 and Pfs230 sequences, designed to elicit functional antibodies that prevent sporozoite invasion of human hepatocytes (PfCSP) and parasite development in mosquitoes (Pfs48/45 and Pfs230). ProC6C formulated on Alhydrogel was evaluated in combination with Matrix-M in a Phase 1 trial in Burkina Faso. The PfCSP antibody responses were assessed for magnitude, specificity, avidity and functionality.

View Article and Find Full Text PDF

Chondroitin sulfate sponge scaffold for slow-release Mg/Cu in diabetic wound management: Hemostasis, effusion absorption, and healing.

Int J Biol Macromol

December 2024

School of Basic Medicine, Jinzhou Medical University, No.40, Section 4, Road Songpo, Jinzhou, Liaoning 121001, PR China. Electronic address:

The management of diabetic wounds presents significant challenges due to persistent inflammation, microenvironmental disruptions, and impaired angiogenesis. To address these issues, this study developed a multifunctional chondroitin sulfate sponge (CSP@Cu-Mg) with anti-inflammatory properties, hemostatic effects, effusion absorption, and enhanced healing promotion. Through ion crosslinking, MgO and CuO were incorporated into the interpenetrating network structure of chondroitin sulfate and acellular dermal matrix, resulting in a sponge with impressive liquid absorption capacity (3450 %) and porosity (83 %).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!